HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Douglas E Brenneman Selected Research

SALLRSIPA

9/2005Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome.
6/2004Protective peptides that are orally active and mechanistically nonchiral.
10/2002Vasoactive intestinal peptide mRNA and immunoreactivity are decreased in fetal alcohol syndrome model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Douglas E Brenneman Research Topics

Disease

5Fetal Alcohol Spectrum Disorders
09/2005 - 10/2002
3Peripheral Nervous System Diseases (PNS Diseases)
09/2022 - 08/2019
3Fetal Death
09/2005 - 10/2002
2Alzheimer Disease (Alzheimer's Disease)
05/2010 - 09/2003
2Craniocerebral Trauma (Head Injury)
04/2005 - 02/2002
2Closed Head Injuries
04/2005 - 02/2002
1Neuralgia (Stump Neuralgia)
09/2022
1Nociceptive Pain
01/2021
1Pain (Aches)
01/2021
1Hyperalgesia
08/2019
1Generalized Epilepsy
11/2013
1Seizures (Absence Seizure)
11/2013
1Epilepsy (Aura)
11/2013
1Drug Resistant Epilepsy
01/2009
1Confusion (Bewilderment)
01/2007
1Parkinson Disease (Parkinson's Disease)
01/2006
1Muscle Hypotonia (Hypotonia)
01/2006
1Cognitive Dysfunction
09/2003
1Down Syndrome (Down's Syndrome)
09/2003
1Autistic Disorder (Autism)
09/2003
1Trisomy (Trisomies)
09/2003
1Neoplasms (Cancer)
10/2002
1Microcephaly
10/2002
1Neuroblastoma
10/2002
1Lung Neoplasms (Lung Cancer)
10/2002
1Colonic Neoplasms (Colon Cancer)
10/2002
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
04/2002

Drug/Important Bio-Agent (IBA)

6Peptides (Polypeptides)IBA
09/2005 - 02/2002
5Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
01/2006 - 10/2002
4Proteins (Proteins, Gene)FDA Link
01/2006 - 02/2002
3SALLRSIPAIBA
09/2005 - 10/2002
2Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 08/2019
2CannabidiolIBA
01/2021 - 08/2019
2Anticonvulsants (Antiepileptic Drugs)IBA
11/2013 - 01/2009
2Ethanol (Ethyl Alcohol)IBA
01/2009 - 07/2003
2Messenger RNA (mRNA)IBA
09/2003 - 10/2002
1CannabinoidsIBA
09/2022
1Morphine (MS Contin)FDA LinkGeneric
01/2021
1Peptide Hydrolases (Proteases)FDA Link
05/2010
1S-2-O-carbamoyl-1-o-chlorophenyl-ethanolIBA
01/2009
1Antidepressive Agents (Antidepressants)IBA
01/2007
1Antimanic AgentsIBA
01/2007
1Pharmaceutical PreparationsIBA
01/2007
1SynucleinsIBA
01/2006
1CytokinesIBA
09/2005
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
04/2005
1CD11b AntigenIBA
04/2005
1ApolipoproteinsIBA
06/2004
1Amyloid beta-PeptidesIBA
09/2003
1EndopeptidasesIBA
10/2002
1Neprilysin (Neutral Endopeptidase)IBA
10/2002
1phosphoramidonIBA
10/2002
1stearyl- Nle(17)- neurotensin(6- 11)VIP(7- 28)IBA
10/2002
1Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA
10/2002
1salicylhydroxamic acid (SHAM)IBA
02/2002
1Amino AcidsFDA Link
02/2002

Therapy/Procedure

3Drug Therapy (Chemotherapy)
09/2022 - 08/2019
1Aftercare (After-Treatment)
06/2004
1Therapeutics
10/2002
1Craniotomy
04/2002
1Electrocoagulation (Electrocautery)
04/2002